Director of Diagnostics (California Medical Groups & IPAs) at BillionToOne

California, United States

BillionToOne Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, Diagnostics, Medical TechnologyIndustries

Requirements

  • Bachelor’s degree in Life Sciences, Healthcare Administration, Business, or a related field; advanced degree preferred
  • Minimum of 5 years’ experience in market access, reimbursement, or healthcare consulting—preferably in diagnostics, biotech, or medical devices
  • Deep knowledge of California’s healthcare delivery system, with specific experience working with medical groups and IPAs
  • Proven track record in payer negotiations and reimbursement strategy execution
  • Exceptional communication, interpersonal, and stakeholder engagement skills
  • Strong analytical skills with the ability to translate complex data into impactful strategies
  • Highly self-driven, well-organized, and capable of working independently in a fast-paced environment

Responsibilities

  • Develop and nurture strategic relationships with decision-makers in medical groups, IPAs, and healthcare systems across California
  • Design and implement market access strategies to secure favorable coverage and reimbursement for our diagnostic solutions
  • Partner cross-functionally with Sales, Marketing, Clinical, and Reimbursement teams to align on access and commercialization priorities
  • Articulate the clinical utility and economic value of our diagnostics to healthcare providers and key stakeholders
  • Monitor and interpret legislative, regulatory, and payer policy developments affecting diagnostic access within the state
  • Lead payer engagement, including contract negotiations, coverage submissions, and the development of reimbursement dossiers
  • Provide actionable insights and data to inform pricing, contracting, and access decisions
  • Track competitor market access activities and adapt strategy in a dynamic and competitive environment

Skills

Market Access
Reimbursement Strategy
Stakeholder Management
Provider Networks
Strategic Planning
Healthcare Ecosystem
Payer Relations

BillionToOne

Molecular diagnostics for prenatal and oncology testing

About BillionToOne

BillionToOne specializes in molecular diagnostics within the healthcare sector, focusing on prenatal screening and oncology testing. Their proprietary QCT technology allows for the detection and quantification of diseases at a single base-pair resolution, enabling the identification of minute variations in DNA. The company offers two main products: Northstar Select™, which helps determine the best initial therapy for patients, and Northstar Response™, which tracks the effectiveness of that therapy. Unlike many competitors, BillionToOne emphasizes accuracy, efficiency, and accessibility in molecular testing, providing diagnostic services directly to healthcare providers. Their goal is to positively impact healthcare by making molecular testing more reliable and available to everyone.

Menlo Park, CaliforniaHeadquarters
2016Year Founded
$380.2MTotal Funding
SERIES_DCompany Stage
Biotechnology, HealthcareIndustries
201-500Employees

Benefits

Competitive pay
Retirement savings package
Parental leave
Free snacks & lunches
Medical, dental, & vision premiums
On campus perks
Free-on-site EV charging

Risks

Emerging biotech startups could threaten BillionToOne's market share.
Rapid technological advancements may render their current technology obsolete.
Expansion into new facilities may face operational challenges or delays.

Differentiation

BillionToOne's QCT technology detects DNA variations at single base-pair resolution.
Their UNITY Fetal Antigen NIPT is the first US cfDNA test for fetal antigen genotyping.
They replace invasive amniocentesis with a safe, affordable blood test for prenatal screening.

Upsides

BillionToOne achieved a billion-dollar valuation with a $130 million funding round.
Their new Austin facility will create 1,000 jobs, boosting production and local economy.
Recognition as Diagnostics Company of the Year highlights their industry leadership.

Land your dream remote job 3x faster with AI